Holen Sie sich die Stockscreener-App
0.9363
0.68%
0.0063
Schlusskurs vom Vortag:
$0.93
Offen:
$0.92
24-Stunden-Volumen:
272.74K
Relative Volume:
2.13
Marktkapitalisierung:
$29.38M
Einnahmen:
$7.11M
Nettoeinkommen (Verlust:
$-41.28M
KGV:
-0.7551
EPS:
-1.24
Netto-Cashflow:
$-26.84M
1W Leistung:
-9.97%
1M Leistung:
-23.88%
6M Leistung:
-11.67%
1J Leistung:
-13.31%
1-Tages-Spanne:
$0.88
$0.9816
1-Wochen-Bereich:
$0.88
$1.0799
52-Wochen-Spanne:
$0.88
$2.2299
Co Diagnostics Inc Stock (CODX) Company Profile
Firmenname
Co Diagnostics Inc
Sektor
Branche
Telefon
(801) 278-9769
Adresse
4049 SOUTH HIGHLAND DRIVE, SALT LAKE CITY
Vergleichen Sie CODX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CODX
Co Diagnostics Inc
|
0.9363 | 29.38M | 7.11M | -41.28M | -26.84M | -1.24 |
|
ABT
Abbott Laboratories
|
118.95 | 208.18B | 41.22B | 5.77B | 6.49B | 2.94 |
|
SYK
Stryker Corp
|
388.14 | 148.70B | 21.97B | 3.59B | 3.21B | 6.74 |
|
BSX
Boston Scientific Corp
|
90.75 | 133.32B | 15.91B | 1.79B | 1.89B | 0.82 |
|
MDT
Medtronic Plc
|
86.27 | 111.27B | 33.00B | 4.29B | 5.50B | 2.71 |
|
EW
Edwards Lifesciences Corp
|
72.07 | 42.66B | 6.60B | 4.16B | 490.10M | 2.34 |
Co Diagnostics Inc Stock (CODX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-08-12 | Herabstufung | Sidoti | Buy → Neutral |
| 2021-12-29 | Eingeleitet | Sidoti | Buy |
| 2021-03-29 | Herabstufung | Maxim Group | Buy → Hold |
| 2020-05-20 | Hochstufung | Maxim Group | Hold → Buy |
| 2020-05-18 | Bestätigt | H.C. Wainwright | Buy |
| 2020-03-09 | Bestätigt | H.C. Wainwright | Buy |
| 2020-03-03 | Herabstufung | Maxim Group | Buy → Hold |
Alle ansehen
Co Diagnostics Inc Aktie (CODX) Neueste Nachrichten
Co-Diagnostics (HAM:C97) Cash Flow from Operations : €-23.54 Mil (TTM As of Sep. 2024) - GuruFocus.com
Co-Diagnostics (HAM:C97) Forward Rate of Return (Yacktman) % : 0.00% (As of Sep. 2024) - GuruFocus.com
Co-Diagnostics, Inc. to Accompany Utah Governor and WTC Utah on Trade Mission to South Korea and Japan - GuruFocus.com
CODX (Co-Diagnostics) 3-Year Book Growth Rate : 5.60% (As of Sep. 2024) - GuruFocus.com
CODX (Co-Diagnostics) Momentum Rank : 8 (As of Nov. 26, 2024) - GuruFocus.com
Co-Diagnostics, Inc. to Host Booth at the 2024 UHCA/UCAL Fall Convention & Expo on Oct 2-3 - GuruFocus.com
Co-Diagnostics stock hits 52-week low at $1 amid market challenges By Investing.com - Investing.com South Africa
Co-Diagnostics stock hits 52-week low at $1 amid market challenges - Investing.com Nigeria
CODX (Co-Diagnostics) 3-Year EPS without NRI Growth Rate : 0.00% (As of Sep. 2024) - GuruFocus.com
Co-Diagnostics, Inc. Reports Third Quarter 2024 Financial Results - GuruFocus.com
Co-Diagnostics (LTS:0A50) Total Liabilities : $8.60 Mil (As of Sep. 2024) - GuruFocus.com
Daxor (NASDAQ:DXR) & Co-Diagnostics (NASDAQ:CODX) Critical Survey - Defense World
Co-Diagnostics, Inc. (CODX) Reports Q3 Loss, Tops Revenue Estimates - MSN
Co-Diagnostics Q3 2024 Earnings Preview - MSN
Co-Diagnostics Third Quarter 2024 Earnings: Beats Expectations - Simply Wall St
Co-Diagnostics, Inc. (NASDAQ:CODX) Q3 2024 Earnings Call Transcript - Insider Monkey
Earnings call: Co-Diagnostics reports decreased Q3 revenue, eyes growth By Investing.com - Investing.com Australia
Co-Diagnostics Inc (CODX) Q3 2024 Earnings Call Highlights: Navi - GuruFocus.com
Co-Diagnostics Inc (CODX) Q3 2024 Earnings Call Highlights: Navigating Revenue Decline and ... - Yahoo Finance
Co-Diagnostics Reports Q3 2024 Financial Results - TipRanks
Co-Diagnostics earnings beat by $0.01, revenue topped estimates - Investing.com UK
CODX (Co-Diagnostics) GF Value Rank : 0 (As of Nov. 05, 2024) - GuruFocus.com
Co-Diagnostics, Inc. to Host Booth at MEDICA Trade Fair in Düsseldorf, Germany on Nov 11-14, 2024 - PR Newswire
Co-Diagnostics to Showcase PCR Innovation at World's Largest Medical Trade Fair MEDICA 2024 | CODX Stock News - StockTitan
Analyzing Insulet (NASDAQ:PODD) and Co-Diagnostics (NASDAQ:CODX) - Defense World
Co-Diagnostics, Inc. Announces Third Quarter 2024 Earnings Relea - GuruFocus.com
Is Co-Diagnostics (NASDAQ:CODX) In A Good Position To Deliver On Growth Plans? - Yahoo Finance
Co-Diagnostics, Inc. Announces Third Quarter 2024 Earnings Release Date and Webcast - BioSpace
Infectious Disease Diagnostics Market to Reach USD 43.09 Billion by 2031 | SkyQuest Technology - Benzinga
Co-Diagnostics, Inc. to Host Booth at Medlab Africa in Cape Town on Oct 22-24, 2024 - PR Newswire
Some of the Key Players in the Emerging Infectious Disease Diagnostics Market : - InsightAce Analytic
Co-Diagnostics Inc (CODX) Q2 2024 Earnings Call Highlights: Revenue Surge Amidst Regulatory Hurdles - Yahoo Finance
The APAC Coronavirus Test Kits Market is projected to grow by USD 2.87 Billion (2024-2028), driven by increased availability of test kits and AI-powered market evolutionTechnavio - Lelezard
In-vitro Diagnostics Kit Market is Expected to See a Growth of 4.40% CAGR from 2024 to 2034 | Future Market Insights, Inc. – Market Research Blog - Market Research Blog
Coronavirus Test Kits Market in North America to Shrink by USD 1.41 Billion (2024-2028) as Integration with Routine Healthcare Evolves, AI-Powered Report by Technavio - The Malaysian Reserve
Co-Diagnostics, Inc. (NASDAQ:CODX) Short Interest Down 30.9% in September - Defense World
Co-Diagnostics (CODX) Price Target Increased by 50.00% to 3.06 - MSN
Co-Diagnostics Inc Inc. (CODX) Price Performance: A Comparative Analysis with Competitors - The InvestChronicle
Co-Diagnostics' Mpox test effective against new clade - Investing.com
Co-Diagnostics completes updated clade Ib analysis of 2-Gene Mpox RUO test - TipRanks
Co-Diagnostics, Inc. Completes Updated Clade Ib Analysis of 2-Gene Mpox RUO Test - PR Newswire
Multiplex Assay Market to Soar USD 6.75 Bn by 2034: Projections Show 4x Growth Driven by Innovations in Diagnostics and Drug Discovery - BioSpace
How does Co-Diagnostics Inc (CODX) change from a tortoise to a hare? - SETE News
Balance Sheet Insights: Co-Diagnostics Inc (CODX)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex
Co-Diagnostics Inc (CODX) shows promising results - US Post News
Co-Diagnostics sees shareholder backing in annual meeting votes By Investing.com - Investing.com South Africa
Co-Diagnostics sees shareholder backing in annual meeting votes - Investing.com
Closing Bell Recap: Co-Diagnostics Inc (CODX) Ends at 1.58, Reflecting a -9.71 Downturn - The Dwinnex
Co-Diagnostics Inc (CODX) presents a great opportunity, but the stock is slightly undervalued - US Post News
Are Medical Stocks Lagging Context Therapeutics Inc. (CNTX) This Year? - Yahoo Finance
Finanzdaten der Co Diagnostics Inc-Aktie (CODX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):